Patents by Inventor Taiki HAMABATA

Taiki HAMABATA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12285434
    Abstract: An object of the present invention is to provide a novel agent for treating, preventing or improving an inflammatory disease or an allergic disease. The present invention provides an agent for treating, preventing or improving an allergic disease, or as an agent for treating, preventing or improving an inflammatory disease or an allergic disease, comprising, as an active ingredient, (±) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid (5,6-DiHETE). The inflammatory disease can be an inflammatory disease due to an increase of calcium concentration in vascular endothelial cells, and the inflammatory disease can be an inflammatory disease developed in a tissue or organ selected from the group consisting of digestive organs, circulatory organs, respiratory organs, urinary organs, genital organs, brain, skin, eyes, and fat.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: April 29, 2025
    Assignee: THE UNIVERSITY OF TOKYO
    Inventors: Takahisa Murata, Tatsuro Nakamura, Taiki Hamabata, Kohei Ashina
  • Publication number: 20220008435
    Abstract: An object of the present invention is to provide a novel agent for treating, preventing or improving an inflammatory disease or an allergic disease. The present invention provides an agent for treating, preventing or improving an allergic disease, or as an agent for treating, preventing or improving an inflammatory disease or an allergic disease, comprising, as an active ingredient, (±) 5,6-dihydroxy-8Z,11Z,14Z,17Z-eicosatetraenoic acid (5,6-DiHETE). The inflammatory disease can be an inflammatory disease due to an increase of calcium concentration in vascular endothelial cells, and the inflammatory disease can be an inflammatory disease developed in a tissue or organ selected from the group consisting of digestive organs, circulatory organs, respiratory organs, urinary organs, genital organs, brain, skin, eyes, and fat.
    Type: Application
    Filed: December 17, 2019
    Publication date: January 13, 2022
    Inventors: Takahisa Murata, Tatsuro Nakamura, Taiki Hamabata, Kohei Ashina
  • Publication number: 20190049472
    Abstract: This biomarker is a biomarker for testing a food allergy, and comprises at least one species selected from the group consisting of LTE4, 14,15-LTE4, 11-trans LTE4, 11-dehydro 11-dehydro TXB2, 2,3-dinor-8-iso Prostaglandin F2?, 13,14-dihydro-15-keto-tetranor PGF1?, 6,15-diketo-13,14-dihydro PGF1?, tetranor-PGFM, 20-OH PGE2, PGE3, PGD3, 13,14-dihydro-15-keto-tetranor PGD2, and 13,14-dihydro-15-keto-tetranor PGE2.
    Type: Application
    Filed: January 27, 2017
    Publication date: February 14, 2019
    Applicant: The University of Tokyo
    Inventors: Takahisa MURATA, Tatsuro NAKAMURA, Taiki HAMABATA